ibio (1).jpg
iBio Reports Fiscal First Quarter 2021 Financial Results and Provides Corporate Update
November 16, 2020 16:05 ET | iBio, Inc.
BRYAN, Texas, Nov. 16, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced its...
ibio (1).jpg
iBio to Participate in Alliance Global Partners’ Virtual Healthcare Symposium
November 12, 2020 08:00 ET | iBio, Inc.
BRYAN, Texas, Nov. 12, 2020 (GLOBE NEWSWIRE) --  iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced that...
ibio (1).jpg
iBio to Report Fiscal 2021 First Quarter Financial Results and Provide Corporate Update on Monday, November 16 ,2020
November 05, 2020 16:30 ET | iBio, Inc.
BRYAN, Texas, Nov. 05, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, announced today that it will...
ibio (1).jpg
iBio Announces Appointment of Randy J. Maddux as Chief Operating Officer
November 03, 2020 07:30 ET | iBio, Inc.
BRYAN, Texas, Nov. 03, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced the...
ibio (1).jpg
Accomplished Financial Executive, Gary Sender, Joins iBio’s Board of Directors
October 15, 2020 16:05 ET | iBio, Inc.
- Adds More Than 25 Years of Financial Leadership in Pharma/Biotech to the Team -  - To Chair iBio’s Audit Committee and be Appointed to the Board’s Compensation Committee - BRYAN, Texas, Oct. 15,...
ibio (1).jpg
iBio Announces Appointment of Dr. Alexandra Kropotova to Board of Directors
October 15, 2020 07:30 ET | iBio, Inc.
- Senior Biopharm Executive with 20 Years of Immuno-Inflammatory Disease Therapeutic Experience - -To be Appointed to the Board’s New Science & Technology Committee - BRYAN, Texas, Oct. 15,...
ibio (1).jpg
iBio Announces Appointment of Dr. Linda Armstrong to Board of Directors
October 14, 2020 16:05 ET | iBio, Inc.
- Accomplished Biopharm Exec with Years of Clinical Experience in Respiratory Diseases - - To be Appointed to the Board’s New Science & Technology Committee - BRYAN, Texas, Oct. 14, 2020 ...
ibio (1).jpg
iBio Announces Financial Results for Fiscal Year Ended June 30, 2020
October 13, 2020 16:05 ET | iBio, Inc.
BRYAN, Texas, Oct. 13, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced its...
ibio (1).jpg
iBio Regains Compliance with NYSE American Continued Listing Standards
October 05, 2020 07:30 ET | iBio, Inc.
NEW YORK, Oct. 05, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, announced today that on...
ibio (1).jpg
iBio Enters into Agreement with Safi Biosolutions to Develop Growth Factors and Cytokines Using the FastPharming® System
October 02, 2020 07:00 ET | iBio, Inc.
- Project Focused on Proteins used in the Production of Blood Cells - NEW YORK, Oct. 02, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) (“iBio” or the “Company”), a biotech innovator and...